Biologicals

Editor's Note
pp. 173-173(1)

WHO Requirements for the Use of Animal Cells asin vitroSubstrates for the Production of Biologicals (Requirements for Biological Susbstances No. 50)
pp. 175-193(19)

WHO Guidelines for the Production and Control of the Acellular Pertussis Component of Monovalent or Combined Vaccines
pp. 195-204(10)

WHO Guidelines for Assuring the Quality of DNA Vaccines
pp. 205-212(8)

Precise Quantitation of Human Parvovirus B19 DNA in Biological Samples by PCR
pp. 213-216(4)
Authors: Gruber F.; Falkner F.G.; Dorner F.; Hammerle T.

Single Radial Immunodiffusion as a Method for the Assay of the Acellular Pertussis Vaccine Components, Pertussis Toxoid, Filamentous Haemagglutinin and Pertactin
pp. 217-224(8)
Authors: Xing D.K.L.; Canthaboo C.; Corbel M.J.; Schild G.C.

Quality Controls andin vitroDiagnostic Efficiency of Bovine PPD Tuberculins
pp. 225-235(11)
Authors: Tameni S.; Amadori M.; Scaccaglia P.; Quondam-Giandomenico R.; Tagliabue S.; Achetti I.L.; Adone R.; Ciuchini F.

Inactivation Kinetics of Model and Relevant Blood-borne Viruses by Treatment with Sodium Hydroxide and Heat
pp. 237-244(8)
Authors: Borovec S.; Broumis C.; Adcock W.; Fang R.; Uren E.

Laboratory Tests for Live Attenuated Poliovirus Vaccine
pp. 245-246(2)
Author: Arya S.C.

Preclinical and Clinical Development of New Vaccines
pp. 247-251(5)
Authors: Plotkin S.; Andre F.; Poolman J.; Robbins J.; Salisbury D.; Wood D.